Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CRON stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CRON investment potential.

What is CRON stock price today?

Get real-time CRON stock price, historical data, and price charts on Financhill. Track CRON performance with our advanced analysis tools.

Is CRON a good investment?

Evaluate CRON investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CRON stock?

To buy CRON stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CRON?

View detailed market capitalization data and company valuation metrics for CRON on our comprehensive analysis page.

What is the P/E ratio of CRON?

Use our fundamental analysis tools to view CRON P/E ratio and compare valuation metrics with industry peers.

What are CRON earnings?

View CRON earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cronos Group, Inc. 10K Form

Buy

CRON
Cronos Group, Inc.

Last Price:

$2.49

Seasonality Move:

39.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-26	10K	CRON/Cronos Group, Inc. Annual
2020-11-05	10Q	CRON/Cronos Group, Inc. Quarterly
2020-08-06	10Q	CRON/Cronos Group, Inc. Quarterly
2020-05-08	10Q	CRON/Cronos Group, Inc. Quarterly
2020-03-30	10K	CRON/Cronos Group, Inc. Annual
2020-03-02	10K	CRON/Cronos Group, Inc. Annual

Receive CRON News And Ratings

See the #1 stock for the next 7 days that we like better than CRON

CRON Financial Statistics

Sales & Book Value

Annual Sales:	$117.6M
Cash Flow:	$8.9M
Price / Cash Flow:	134.64
Annual Sales:	$2.83
Price / Book:	0.88

Profitability

EPS (TTM):	0.09340
Net Income (TTM):	$41.5M
Gross Margin:	$21.5M
Return on Equity:	3.69%
Return on Assets:	3.54%

Cronos Group, Inc. Earnings Forecast

Key Cronos Group, Inc. Financial Ratios

The Gross Profit Margin over the past 11 years for CRON is 18.28%.
The Selling, General & Administrative Expenses for CRON have been equal to 57.92% of Gross Profit Margin.
The Research & Development expenses have been 3.60% of Revenue.
The Interest Expense is 0.00% of Operating Income.
The Net Earning history of CRON is 34.03% of Total Revenues.
Per Share Earnings over the last 11 years have been positive in 6 years.

Cronos Group, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	CRON
CUSIP:	22717L
Website:	thecronosgroup.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	22.45
Quick Ratio:	20.73

Price-to-Earnings

Trailing P/E Ratio:	23.38
Forward P/E Ratio:	0

CRON Technical Analysis vs Fundamental Analysis

Buy

Cronos Group, Inc. (CRON) is a Buy

Is Cronos Group, Inc. a Buy or a Sell?

Cronos Group, Inc. stock is rated a Buy

The current Cronos Group, Inc. [CRON] share price is $2.49. The Score for CRON is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.